PBMI Specialty Pharmacy Forum

Jeffrey A. Shaman, Ph.D., chief science officer at Coriell Life Sciences, talked about how pharmacogenomics can inform medication management.

Kali Panagos, Pharm.D., at ARMSRx, discusses the growing trend of copay assistance programs and alternative funding solutions that can help provide access to expensive specialty therapies.

William Trombatt and James Adams of AllianceRx Walgreens Prime discussed specialty pharmacy for people with MS at PBMI Specialty Rx Forum last week. The need for "higher touch" programs is important for people with MS, said Adams.

Prior authorization and other utilization management strategies may cause harmful delays in therapy in oncology and for diseases such as multiple sclerosis, say panelists at PBMI's 4th Annual Specialty Rx Forum.

McKesson VP says implementing patient-centeredness involves 13 different types of professionals.

Alex Jung of EY-Parthenon, Ernst & Young LLP, explains why therapies in new era of drug treatment are so expensive and what can be done about it.

Featured speaker at the 4th Annual PBMI Specialty Rx Forum on October 16 discusses theme of the meeting.